Detail Drug Information

Orciprenaline sulphate (Orciprenaline sulphate)

Overview of Orciprenaline sulphate

Orciprenaline (Sulphate) is a beta-receptor agonist, used in the management of bronchial asthma.

Indication of Orciprenaline sulphate

Orciprenaline Sulphate is primarily indicated in conditions like Asthma, Bronchitis, Obstructive airway disease, and can also be given in adjunctive therapy as an alternative drug of choice in Bradycardia, Reversible airways obstruction.

Contraindication of Orciprenaline sulphate

Orciprenaline (Sulphate) is contraindicated in conditions like Cardiac arrhythmia,Diabetes mellitus,Myocardial infarction,Thyrotoxicosis,Ischaemic heart disease,Cystic fibrosis,Aortic stenosis,Quadriplegia.

Side Effects of Orciprenaline sulphate

The severe or irreversible adverse effects of Orciprenaline (Sulphate), which give rise to further complications include Intolerable muscle tremors, Extra systoles.,Orciprenaline (Sulphate) produces potentially life-threatening effects which include Ventricular arrhythmias, Deterioration of asthma. which are responsible for the discontinuation of Orciprenaline (Sulphate) therapy.,The signs and symptoms that are produced after the acute overdosage of Orciprenaline (Sulphate) include Nausea, Tachycardia, Headache, Tremor, Restlessness, Anxiety, BP changes, Excitement.,The symptomatic adverse reactions produced by Orciprenaline (Sulphate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Nausea, Palpitation, Tachycardia, Nervousness, SweatingX, Hypotension, Tremor, Taste disturbance, Hypokalemia, Hyperglycemia, nervousness, Nervousness, dizziness, Hypotension, Tachycardia.

Precautions of Orciprenaline sulphate

Orciprenaline should not be used in the patient with hypothyroidism, diabetes mellitus, hypertension, cardiac arrhythmias, ischemic heart disease, seizures or hypersensitivity to sympathomometics (pheochromocytoma). The safe use of drug during pregnancy has not been established. The inhaled Orciprenaline should be used with great caution in the children under the age of 12 years.